The effects of continuous administration of diazepam on the recovery of lesion-induced nystagmus in unilaterally labyrinthectomised rats

Acta Otolaryngol. 2023 Aug;143(8):675-680. doi: 10.1080/00016489.2023.2241511. Epub 2023 Aug 22.

Abstract

Background: Diazepam, a gamma-aminobutyric acid type A receptor agonist, is classified as a vestibular suppressant and is effective in treating acute vertigo. However, its effects on vestibular compensation (VC) remain unclear.

Objectives: We examined the effects of continuous administration of diazepam on the frequency of spontaneous nystagmus (SN) after unilateral labyrinthectomy (UL) as an index of the initial process of VC in rats.

Materials and methods: Diazepam was continuously administered at doses of 3.5 and 7.0 mg/kg/day, intraperitoneally, via an osmotic minipump. The frequency of SN beating against the lesion side after UL was measured. Potassium chloride (KCl) solution (1 M) was injected intratympanically to induce SN beating to the injection side.

Results: Continuous administration of diazepam significantly and dose-dependently decreased the frequency of SN after UL, and also reduced the x intercept of the nonlinear regression curve of the decline in UL-induced SN with time in rats. However, the continuous administration of diazepam did not affect the frequency of intratympanic KCl-induced SN in the rats.

Conclusion: These findings suggested that continuous administration of diazepam accelerates the initial process of VC; however, it does not suppress the nystagmus-driving mechanisms in rats.

Keywords: GABA; Vestibular compensation; diazepam; rats; spontaneous nystagmus; unilateral labyrinthectomy.

MeSH terms

  • Animals
  • Diazepam / therapeutic use
  • Nonoxynol
  • Nystagmus, Pathologic* / drug therapy
  • Nystagmus, Pathologic* / etiology
  • Rats
  • Vertigo
  • Vestibule, Labyrinth*

Substances

  • Diazepam
  • Nonoxynol